AstraZeneca Recognized as a Top Company for Female Executives

WILMINGTON, Del.--(BUSINESS WIRE)-- The National Association for Female Executives (NAFE) today named AstraZeneca (NYSE: AZN) as one of the top 50 companies for female executives for the third consecutive year.

NAFE recognizes organizations for policies and practices that encourage women’s advancement, and in particular, the number of women holding executive positions in the business. Within AstraZeneca, women lead key teams and functions, including the vice president of Marketing and Sales Operations, vice president of North America Operations, vice president of Specialty Care and chief global veterinary officer.

“AstraZeneca focuses on identifying and nurturing the talents, abilities and skill sets of women within the organization,” said Jayne Stanier, vice president, Human Resources, North America. “Our aim is to foster an environment that encourages employees to reach their aspirations and career goals by building on their strengths and providing development opportunities.”

AstraZeneca offers programs that contribute to a supportive working culture for women, including:

  • Career development and mentoring programs, including support for women’s advancement
  • Diverse employee network groups, including the “AZ Network of Women”
  • Work/life resource and employee assistance programs providing confidential, personal support, resources and referrals to help solve a wide range of personal and work-related challenges

About NAFE

The National Association for Female Executives (NAFE), founded in 1972, serves 20,000 members nationwide with networking, tools and solutions to strengthen and grow their careers and businesses. NAFE magazine publishes the annual Top Companies issue and the annual Women of Excellence issue. NAFE.com provides up-to-date information, community for women in business and access to member benefits. NAFE is a division of Working Mother Media and Bonnier Corporation.

About AstraZeneca

AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialization of prescription medicines for gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious disease. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.

For more information about AstraZeneca in the U.S. or our AZ&Me™ Prescription Savings programs, please visit: www.astrazeneca-us.com or call 1-800-AZandMe (292-6363).



CONTACT:

Media Inquiries:
AstraZeneca
Katie Lubenow, 302-885-9960

KEYWORDS:   United States  North America  Delaware

INDUSTRY KEYWORDS:   Women  Health  Biotechnology  Pharmaceutical  Professional Services  Human Resources  Consumer  General Health

MEDIA:

Logo
 Logo

Suggested Articles

Belén Garijo, currently CEO of Merck Healthcare, will succeed Stefan Oschmann as the German company's chief exec when his tenure ends in April 2021.

More than 60 researchers and bioethicists called on Pfizer to take time to collect more COVID-19 vaccine safety data, Bloomberg reports. 

Leaked details about an ad campaign to quell coronavirus fears before the election raise "every red flag I could dream of," an ex-HHS official said.